Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain

Huijing Wang(The University of Texas MD Anderson Cancer Center), Annemieke Kavelaars(The University of Texas MD Anderson Cancer Center)

Journal of Clinical Investigation

November 14, 2013

10.1172/jci66241

Cited by 97

Related Papers

GRK2: A Novel Cell-Specific Regulator of Severity and Duration of Inflammatory Pain

|Journal of Neuroscience|2010|106

CD8+ T cell–derived IL-13 increases macrophage IL-10 to resolve neuropathic pain

|JCI Insight|2022|93

Low Nociceptor GRK2 Prolongs Prostaglandin E<sub>2</sub>Hyperalgesia via Biased cAMP Signaling to Epac/Rap1, Protein Kinase Cε, and MEK/ERK

|Journal of Neuroscience|2010|88

G Protein-Coupled Receptor Kinase 6 Acts as a Critical Regulator of Cytokine-Induced Hyperalgesia by Promoting Phosphatidylinositol 3-Kinase and Inhibiting p38 Signaling

|Molecular Medicine|2012|27